Marc Pipas, MD

Trials

Studies that name Marc Pipas, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:33 UTC. Open this list on ClinicalTrials.gov

• Ph2
  NCT03241810 · Phase 2 Trial of Seribantumab Plus Fulvestrant in Postmenopausal Women With Metastatic Breast Cancer

  Elevation Oncology · terminated · Metastatic Breast Cancer · study director
• Ph1
  NCT01181245 · A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer

  Kyntra Bio · completed · Locally Advanced or Metastatic Pancreatic Cancer · principal investigator
• Early Ph1
  NCT01015300 · Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease

  Dartmouth-Hitchcock Medical Center · terminated · Hemangioblastomas, Von Hippel Lindau Disease · principal investigator
• N/A
  NCT00225745 · Ghrelin Levels in Pancreatic Cancer Patients

  Dartmouth-Hitchcock Medical Center · completed · Pancreatic Cancer · principal investigator
• Ph2
  NCT00225784 · Cetuximab, Radiotherapy and Twice Weekly Gemcitabine to Treat Pancreatic Cancer

  Dartmouth-Hitchcock Medical Center · completed · Pancreatic Cancer · principal investigator

Grants

NIH projects from RePORTER, fetched 2026-11-12 11:33 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.